Livzon Pharmaceutical completes RMB 3m share buyback program

Livzon Pharmaceutical Group completed its most recent share buyback on August 5, purchasing 72,100 A-shares at prices between RMB 41.37 and RMB 41.85, totaling RMB 2,996,146 on the Shenzhen Stock Exchange.

The buybacks are part of a broader repurchase program spanning from December 2024 to August 2025, with individual transactions ranging from 1,700 to 561,400 shares. The repurchased shares are currently held by the company and have not been cancelled.